Rahul Kumar Verma

3.2k total citations
92 papers, 2.3k citations indexed

About

Rahul Kumar Verma is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Rahul Kumar Verma has authored 92 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Pulmonary and Respiratory Medicine, 22 papers in Pharmaceutical Science and 14 papers in Molecular Biology. Recurrent topics in Rahul Kumar Verma's work include Inhalation and Respiratory Drug Delivery (28 papers), Advanced Drug Delivery Systems (14 papers) and Drug Solubulity and Delivery Systems (7 papers). Rahul Kumar Verma is often cited by papers focused on Inhalation and Respiratory Drug Delivery (28 papers), Advanced Drug Delivery Systems (14 papers) and Drug Solubulity and Delivery Systems (7 papers). Rahul Kumar Verma collaborates with scholars based in India, United States and Canada. Rahul Kumar Verma's co-authors include Kalpesh Vaghasiya, Ankur Sharma, Lucila Garcia‐Contreras, Mariam Ibrahim, Eupa Ray, Amit Misra, A. Haldar, Krishna Jadhav, Rahul Shukla and Amit Kumar Singh and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Applied Materials & Interfaces and Journal of Controlled Release.

In The Last Decade

Rahul Kumar Verma

87 papers receiving 2.2k citations

Peers

Countries citing papers authored by Rahul Kumar Verma

Since Specialization

Citations

This map shows the geographic impact of Rahul Kumar Verma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rahul Kumar Verma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rahul Kumar Verma more than expected).

Fields of papers citing papers by Rahul Kumar Verma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rahul Kumar Verma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rahul Kumar Verma. The network helps show where Rahul Kumar Verma may publish in the future.

Co-authorship network of co-authors of Rahul Kumar Verma

This figure shows the co-authorship network connecting the top 25 collaborators of Rahul Kumar Verma. A scholar is included among the top collaborators of Rahul Kumar Verma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rahul Kumar Verma. Rahul Kumar Verma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intranasal Therapeutics for Neurodegenerative Disorders: Overcoming the Blood–Brain Barrier with Smart Formulations and Devices 2025 ·Molecular Pharmaceutics ·(unknown), (unknown), Rahul Kumar Verma, Akhilesh Kumar, Piyush Kumar Gupta, Rahul Shukla	2
2	Peptide–Drug Conjugates as Next-Generation Therapeutics: Exploring the Potential and Clinical Progress 2025 ·Bioengineering ·Krishna Jadhav, (unknown), (unknown), Dipak D. Gadade, (unknown), Anand Iyer, Ankur Sharma, Saroja Kumar Rout, Amol D. Gholap, Jitendra Naik, Rahul Kumar Verma, Satish Rojekar	5
3	Intelligently Actuating Dual-Barrier Hyaluronic Acid-Functionalized Inflammation-Responsive Nanohydrogel for Targeted Rheumatoid Arthritis Therapy 2025 ·ACS Applied Materials & Interfaces ·(unknown), (unknown), Krishna Jadhav, (unknown), (unknown), (unknown), Rahul Kumar Verma	1
4	Host-Directed Therapy with Inhalable Lovastatin Microspheres for Matrix Metalloproteinase Inhibition in Tuberculosis 2025 ·ACS Applied Bio Materials ·(unknown), Krishna Jadhav, Rahul Sharma, (unknown), (unknown), Neelesh Sharma, Amit Kumar Singh, Rahul Kumar Verma	3
5	Quality Analysis of Selected Drinking Water of Kolasib District, Northern Mizoram (India) * 2024 ·SSRN Electronic Journal ·Rahul Kumar Verma	0
6	Inhalable chitosan-coated nano-assemblies potentiate niclosamide for targeted abrogation of non-small-cell lung cancer through dual modulation of autophagy and apoptosis 2024 ·International Journal of Biological Macromolecules ·Eupa Ray, Krishna Jadhav, (unknown), (unknown), (unknown), (unknown), (unknown), Anil Kumar, Rahul Kumar Verma	5
7	Breaking the Cycle: Matrix Metalloproteinase Inhibitors as an Alternative Approach in Managing Tuberculosis Pathogenesis and Progression 2024 ·ACS Infectious Diseases ·(unknown), Krishna Jadhav, (unknown), Eupa Ray, Alok Kumar, Amit Singh, Rahul Kumar Verma	5
8	Susceptibility of clinical isolates of novel pathogen Stenotrophomonas sepilia to novel benzoquinolizine fluoroquinolone levonadifloxacin 2024 ·JAC-Antimicrobial Resistance ·(unknown), Nishant Shekhar, Lipika Singhal, (unknown), Ajay Duseja, Rahul Kumar Verma, Kanika Bansal, (unknown), Sanjay Biswas, (unknown), Suneeta Sahu, Prabhu B. Patil, Vikas Gautam	0
9	Recent Developments in Tyrosine Kinase Inhibitor-based Nanotherapeutics for EGFR-resistant Non-small Cell Lung Cancer 2024 ·Current Drug Delivery ·(unknown), Krishna Jadhav, (unknown), (unknown), (unknown), Rahul Kumar Verma, Jitendra Naik	10
10	A critical review on developments in drying technologies for enhanced stability and bioavailability of pharmaceuticals 2024 ·Drying Technology ·Krishna Jadhav, (unknown), (unknown), Saroja Kumar Rout, Rahul Kumar Verma, Aniruddha Chatterjee, Arun S. Mujumdar, Jitendra Naik	15
11	Effective cerebral tuberculosis treatment via nose-to-brain transport of anti-TB drugs using mucoadhesive nano-aggregates 2024 ·Nanoscale ·Krishna Jadhav, (unknown), (unknown), Eupa Ray, (unknown), Awadh Bihari Yadav, Amit Kumar Singh, Rahul Kumar Verma	7
12	Comparative Preclinical Pharmacokinetics and Disposition of Favipiravir Following Pulmonary and Oral Administration as Potential Adjunct Therapy Against Airborne RNA Viruses 2024 ·Pharmaceutical Research ·(unknown), Hasham S. Sofi, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Lubna Azmi, Rahul Kumar Verma, Amit Misra	1
13	Design, Synthesis, Molecular docking, and Antibacterial Study of Aminomethyl Triazolo Substituted Analogues of Benzimidazolo [1,4]-benzodiazepine 2023 ·Journal of Molecular Structure ·Meenu Devi, Shivangi Jaiswal, (unknown), Sonika Jain, Smita Jain, Kanika Verma, Rahul Kumar Verma, Dharma Kishore, Jaya Dwivedi, Swapnil Sharma	20
14	Nanotherapeutics for pulmonary drug delivery: An emerging approach to overcome respiratory diseases 2023 ·Journal of Drug Delivery Science and Technology ·(unknown), Krishna Jadhav, (unknown), Prashik B. Dudhe, Rahul Kumar Verma, Aniruddha Chatterjee, Jitendra Naik	43
15	Formulation development of tocopherol polyethylene glycol nanoengineered polyamidoamine dendrimer for neuroprotection and treatment of Alzheimer disease 2022 ·Journal of drug targeting ·Ajit Singh, Rewati Raman Ujjwal, Saba Naqvi, Rahul Kumar Verma, Sanjay Tiwari, Prashant Kesharwani, Rahul Shukla	22
16	In Vitro Anti-tumoral and Anti-bacterial Activity of an Octamolybdate Cluster-Based Hybrid Solid Incorporated with a Copper Picolinate Complex 2020 ·ACS Applied Bio Materials ·Arti Joshi, Ruby Gupta, Kalpesh Vaghasiya, Rahul Kumar Verma, Deepika Sharma, Monika Singh	13
17	Nanostructured silver decorated hollow silica and their application in the treatment of microbial contaminated water at room temperature 2019 ·New Journal of Chemistry ·S.T. Nishanthi, Krishna K. Yadav, Arabinda Baruah, Kalpesh Vaghasiya, Rahul Kumar Verma, Ashok K. Ganguli, Menaka Jha	20
18	Alginate Microspheres Elicit Innate M1-Inflammatory Response in Macrophages Leading to Bacillary Killing 2019 ·AAPS PharmSciTech ·Kalpesh Vaghasiya, (unknown), Ankur Sharma, Eupa Ray, (unknown), Rahul Kumar Verma	11
19	Supplementation of host response by targeting nitric oxide to the macrophage cytosol is efficacious in the hamster model of visceral leishmaniasis and adds to efficacy of amphotericin B 2016 ·International Journal for Parasitology Drugs and Drug Resistance ·(unknown), Rahul Kumar Verma, Prashant Khare, (unknown), Dadi A. Srinivasarao, Anuradha Dube, Neena Goyal, Amit Misra	10
20	Draw-Bending Analysis of a Cold Rolled DP980 Steel Sheet 2011 ·AIP conference proceedings ·Rahul Kumar Verma, (unknown), Kwansoo Chung, Toshihiko Kuwabara	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact